Organization
Intas Pharmaceuticals Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Intas Pharmaceuticals Ltd.

... Lundbeck AS Heptares Therapeutics Ltd Immodulon Therapeutics Ltd Impel NeuroPharma Inc Intas Pharmaceuticals Ltd IntelGenx Corp Intra-Cellular Therapies Inc Jiangsu Nhwa Pharmaceutical Corp Ltd Johnson ...
... Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited ...
... Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited ...
... Tibor Hlobik (Marketing Directors, West Pharmaceutical Services), Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals), Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies), and ...
... Tibor Hlobik (Marketing Directors, West Pharmaceutical Services), Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals), Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies), and ...
... and Wipro. Vaultize has also won numerous new accounts in India, including Intas Pharmaceuticals, Qatar First Bank, and Yes Bank. Vaultize has captured a growing ...
... facility was primarily supported by a pledge of shares of Accord by Intas Pharmaceuticals, a corporate guarantee by Intas and assignment of shareholder's loan from ...
... Ltd., Hyundai Pharmaceutical Co., Ltd., Impel NeuroPharma, Inc., INSYS Therapeutics, Inc., Intas Pharmaceuticals Ltd., Intra-Cellular Therapies, Inc., INVENT Pharmaceuticals, Inc., Johnson & Johnson, KemPharm, Inc., ...
... would sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for �603m. The sale was part of Teva's deal with the ...
... closed earlier in the year. The buyer is Indian pharmaceutical company Intas Pharmaceuticals Ltd., which via its Accord Healthcare subsidiary has agreed to pay 603 ...
Subscribe now for full coverage on Intas Pharmaceuticals Ltd.
Start My Free Trial